Terms: = Gastric cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10 AND Treatment
2 results:
1. Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.
Santoni M; Guerra F; Conti A; Lucarelli A; Rinaldi S; Belvederesi L; Capucci A; Berardi R
Cancer Treat Rev; 2017 Sep; 59():123-131. PubMed ID: 28818671
[TBL] [Abstract] [Full Text] [Related]
2. The intracellular juxtamembrane domain of discoidin domain receptor 2 (ddr2) is essential for receptor activation and ddr2-mediated cancer progression.
Kim D; Ko P; You E; Rhee S
Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
[TBL] [Abstract] [Full Text] [Related]
